Evidence map›Paper›PMID 40284896›Full record

ArticleViruses2025

Maylla Cardoso de Oliveira, Janaina Nicolau de Oliveira, Eliza Pizarro Castilha, Giulia Mariane Fortunato, Pamella Rodrigues da Silva, Bianca Lisley Barboza Pacheco, José d'Oliveira Couto-Filho, Roberta Losi Guembarovski, Karen Brajão de Oliveira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maylla Cardoso de OliveiraLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
Janaina Nicolau de OliveiraLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
Eliza Pizarro CastilhaLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.ORCID 0000-0003-2020-7482
Giulia Mariane FortunatoLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
Pamella Rodrigues da SilvaLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
Bianca Lisley Barboza PachecoLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
José d'Oliveira Couto-FilhoCancer Hospital of Londrina, Londrina 86015-520, PR, Brazil.
Roberta Losi GuembarovskiDepartment of General Biology, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, Brazil.
Karen Brajão de OliveiraLaboratory of Molecular Genetics and Immunology, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.ORCID 0000-0001-9666-6963

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Finance Code 001
6 · The paper itself

Abstract

High-risk Human Papillomavirus (HPV) infection is the main etiological factor for cervical carcinogenesis, although genetic cofactors also play a role. Single-nucleotide variants (SNVs) in the

Indexed as

CTLA-4 AntigenGenetic Predisposition to DiseaseHaplotypesPapillomavirus InfectionsPolymorphism, Single NucleotideUterine Cervical NeoplasmsAdultAgedAllelesBrazilFemaleGenotypeHumansMiddle AgedPapillomaviridaeYoung AdultCTLA-4 AntigenCTLA4 protein, humanCD152cervical intraepithelial lesionscytotoxic T-lymphocyte-associated antigen-4genetic polymorphismhuman papillomavirus

Identifiers

PMID40284896
PMCPMC12031065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.